Nonetheless, the deep web of links we have reviewed here between NF-κB signaling with both genetic and environmental risks for ALS, should support the continued investigation of manipulating this pathway as a potential intervention to treat this devastating disease. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.